收藏切换
Considerations for Older Adults in New Drug Development and Clinical Research
收藏切换
Duanduan CONG, Ying GENG, Qiang LI, Yanze SUN, Ningning MIN, Zhimin YANG*
Chinese Journal of Pharmaceuticals | 2024, 55(9) : 1282 - 1288
Less
收藏切换
Chinese Journal of Pharmaceuticals | 2024, 55(9): 1282-1288
• Pharmaceutical Management & Information •
Considerations for Older Adults in New Drug Development and Clinical Research
Full
Duanduan CONG, Ying GENG, Qiang LI, Yanze SUN, Ningning MIN, Zhimin YANG*
Affiliations
  • Center for Drug Evaluation, National Medical Products Administration, Beijing 100022
Published: 2024-09-10 doi: 10.16522/j.cnki.cjph.2024.09.017
Outline
收藏切换

As the population ages, the need for medications tailored to older adults becomes increasingly critical. Due to pathophysiological changes, comorbidities, and polypharmacy, older adults may respond differently to drugs than younger individuals. This necessitates targeted drug development and adjusted dosages. However, older adults, particularly those over 80 years of age, are often underrepresented in clinical trials. This lack of research data hinders the safe and effective use of medications in this age group. New drug development and clinical research hold immense potential for improving the well-being of older adults. To achieve this, strong collaboration between governments, pharmaceutical companies, and research institutions is essential. In-depth studies on how medications interact with the aging body are crucial. Furthermore, establishing a robust scientific evaluation system, informed by both policy and scientific advancements, is paramount to ensure the safety and efficacy of medications for older adults. This article explores key considerations for new drug development and clinical research specific to this growing demographic, taking into account both domestic and international regulatory developments.

the older population  /  innovative drug  /  drug regulation  /  clinical design  /  frailty  /  aging-friendly
丛端端, 耿莹, 李强, 孙艳喆, 闵柠柠, 杨志敏. 新药研发与临床研究中对于老年人群的若干考虑. 中国医药工业杂志, 2024 , 55 (9) : 1282 -1288 . DOI: 10.16522/j.cnki.cjph.2024.09.017
Duanduan CONG, Ying GENG, Qiang LI, Yanze SUN, Ningning MIN, Zhimin YANG. Considerations for Older Adults in New Drug Development and Clinical Research[J]. Chinese Journal of Pharmaceuticals, 2024 , 55 (9) : 1282 -1288 . DOI: 10.16522/j.cnki.cjph.2024.09.017
Year 2024 volume 55 Issue 9
23
4
Cite this Article
BibTeX
Article Info
doi: 10.16522/j.cnki.cjph.2024.09.017
  • Receive Date:2024-06-05
  • Online Date:2026-11-20
  • Published:2024-09-10
Article Data
Affiliations
History
  • Received:2024-06-05
Funding
Affiliations
    Center for Drug Evaluation, National Medical Products Administration, Beijing 100022
References
Share
https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2024.09.017
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT